Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Off-label use of recombinant FVIIa: Clinical characteristics that may influence outcomes

Off-label use of recombinant FVIIa: Clinical characteristics that may influence outcomes. Blood. 2005; 11:130A; 431 Part 1.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.